2051 Age and Sex-Specific Morphometric Predictors of Disease Progression and Surgical Outcomes in Degenerative Cervical Myelopathy

View at publisher Summarise with VIRAT
Authors: Fauziyya Muhammad, Kenneth Arnold Weber II, Grace Haynes, Monica Paliwal, Sanaa Hameed, Ali Fahim Khan, Amber Dastgir, Hakeem J Shakir, Mazin Al Tamimi, Michael Van Hal, Michael X. Rohan, Yasin Y. Dhaher
+2 more Todd B. Parrish, Zachary A. Smith
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic spinal cord (SC) dysfunction in adults, yet predictors of disease severity, progression, and treatment response remain poorly defined. In particular, the roles of age, sex, and early spinal cord morphometric changes are underexplored. METHODS: A prospective cohort of 187 participants was enrolled across four institutions: healthy controls (HC, n = 60), individuals with asymptomatic SC compression (ASCC, n = 21), and patients with DCM (n = 106), 30 of whom were followed longitudinally (16 surgical, 14 non-surgical). CSA was extracted from 3T T2-weighted MRI using an automated segmentation pipeline. Associations between CSA, age, sex, and clinical progression were evaluated using ANOVA, mixed-effects models, and survival analysis. mJOA scores assessed disease severity and surgical outcomes. RESULTS: CSA was significantly reduced in DCM patients and ASCC compared to controls (p < 0.001) and declined with age across all groups. At baseline, healthy males had larger CSA (p = 0.002) but exhibited steeper age-related declines (p = 0.004). In DCM, individuals over 50 and males showed greater CSA loss and compression severity. CSA loss correlated strongly with worsening mJOA scores (r = 0.58, p < 0.001). Kaplan-Meier analysis showed accelerated progression in individuals >50 years (p < 0.01). Among ASCC participants who were longitudinally followed (n = 5), 60% showed progressive CSA loss and 33% had worsening of their mJOA score. CONCLUSIONS: Automated CSA measurement is a robust, age- and sex-sensitive imaging biomarker for tracking SC deterioration. This approach enables proactive monitoring of at-risk individuals especially males over 50 who demonstrate faster compression acceleration. These findings support CSA-based surveillance to identify candidates for earlier intervention, personalized treatment decisions, and stratified follow-up in both asymptomatic and early-stage DCM.

Fields of Study & Subjects

Cervical and Thoracic Myelopathy Scoliosis diagnosis and treatment Spinal Dysraphism and Malformations

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
255–256
Publication date
26 March 2026
Language
EN